Dec 28, 2004
Happy Holidays, Thanks for the great work you all do here. It's greatly appreciated. I'm a bit confused about the recent news regarding the success of the French therapeutic vaccine. It seems from what I've read that it was very successful - but I'm no doctor. The biggest criticism seems to be that the treatment was a bit "cumbersome" - as if some of the other HIV treatments aren't. If so many people can have such a great viral reduction as occurred in the French study with only one injection over a year why isn't there more hoopla over this news. As an HIVer I don't feel that the procedure described was too "cumbersome" for me. Not to be a Grinch, but it's frustrating sometimes that the pace of research seems to be glacial. Where is the sense of urgency? Can you shed any light on this vaccine study? Thanks again.
| Response from Dr. Pierone
I agree with your assessment. I think this work represents a potential breakthrough for HIV management. If I were a vaccine researcher, I would be boning up on dendritic cell manipulation and visiting the lab in France to learn their techniques and extend this line of research.
Get Email Notifications When This Forum Updates or Subscribe With RSS
- Can Stress Cause Peripheral Neuropathy?
- Does Peripheral Neuropathy Cause Foot Drop And Toe Curling?
- Can You Get Hiv Or Stds From Receiving Fellatio?
- What Would Be The Changes In Nails In Hiv?
- Having High T-cell Count When Hiv Postive
- What Are The Chances Of Contracting Hiv From A Carrier?
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.